Download Free Sample
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of anima.....
Latin America Swine Vaccines Market: By Vaccine Type, By Disease Type , By Distribution Channel, and Country
Latin America Swine Vaccines Market: By Vaccine Type, By Disease Type , By Distribution Channel, and Country
Latin America Swine Vaccines Market size was valued at US$ x billion in 2022 and is expected to reach US$ x billion by 2029, at a CAGR of x% from 2023 to 2029. Vaccines are the biological preparations that provide acquired immunity to the particular disease. Vaccine typically contains the agent that resembles a disease-causing microorganism and made from the killed or weakened forms of microbe, its surface proteins, or toxins. Swine vaccines are manufactured for the prevention or cure of various diseases in swine. Most commonly occurred diseases in swine include parasitic diseases, foodborne diseases, and infectious diseases among others. These vaccines prevent the diseases and make the swine healthy. The swine flu vaccination industry is growing due to a decline in immunity and an increase in the prevalence of epidemic swine flu infection. Respiratory illnesses are caused by swine flu. It is caused by a virus that mutates quickly, allowing it to penetrate both vaccine-induced and natural protection. This virus can spread from animals to humans, resulting in the emergence of new, potentially pandemic strains.
High demand for healthy pork meat and rise in pork meat production, Rise in prevalence of various infectious and foodborne diseases and expansion of business by the market players, Grow in adoption of newer vaccines and development in economic growth. Restraints: Stringent regulatory policies for the swine vaccine approval, Adverse effects such as allergies associated with the vaccines, High cost of vaccines and lack of awareness about the swine diseases in underdeveloped countries.
Latin America swine vaccines market is divided into Brazil, Mexico, Argentina, Venezuela and Rest of Latin America. Brazil swine vaccines market is expected to grow at significant growth during the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
By Vaccine Type |
|
|
By Disease Type |
|
|
By Distribution Channel |
|
Download Free Sample Report
Zoetis , Merck & Co. Inc, Virbac S.A., Boehringer Ingelheim Vetmedica, Elanco, Bayer Animal Health , Ceva Sante Animale
The report covers the countries market data: Brazil, Mexico, Argentina
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1.Executive Summary |
| 2. Latin America Swine Vaccines Market Introduction |
| 2.1. Latin America Swine Vaccines Market - Taxonomy |
| 2.2. Latin America Swine Vaccines Market - Definitions |
| 2.2.1.Vaccine Type |
| 2.2.2.Disease Type |
| 2.2.3.Distribution Channel |
| 2.2.4.Country |
| 3. Latin America Swine Vaccines Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Latin America Swine Vaccines Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Latin America Swine Vaccines Market By Vaccine Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Inactivated Vaccines |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Recombinant vaccines |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Live attenuated vaccines |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. DNA vaccines |
| 5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Subunit vaccines |
| 5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Others |
| 5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Latin America Swine Vaccines Market By Disease Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Viral Infections |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Bacterial Infections |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Parasitic Infection |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Fungal Infections |
| 6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Latin America Swine Vaccines Market By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Veterinary Hospitals |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Veterinary Pharmacies |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Online Pharmacies |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Latin America Swine Vaccines Market By Country, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. Brazil |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Mexico |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Rest of LA |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Brazil Latin America Swine Vaccines Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. Vaccine Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Inactivated Vaccines |
| 9.1.2.Recombinant vaccines |
| 9.1.3.Live attenuated vaccines |
| 9.1.4.DNA vaccines |
| 9.1.5.Subunit vaccines |
| 9.1.6.Others |
| 9.2. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Viral Infections |
| 9.2.2.Bacterial Infections |
| 9.2.3.Parasitic Infection |
| 9.2.4.Fungal Infections |
| 9.2.5.Others |
| 9.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Veterinary Hospitals |
| 9.3.2.Veterinary Pharmacies |
| 9.3.3.Online Pharmacies |
| 10.Mexico Latin America Swine Vaccines Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Vaccine Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Inactivated Vaccines |
| 10.1.2.Recombinant vaccines |
| 10.1.3.Live attenuated vaccines |
| 10.1.4.DNA vaccines |
| 10.1.5.Subunit vaccines |
| 10.1.6.Others |
| 10.2. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Viral Infections |
| 10.2.2.Bacterial Infections |
| 10.2.3.Parasitic Infection |
| 10.2.4.Fungal Infections |
| 10.2.5.Others |
| 10.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Veterinary Hospitals |
| 10.3.2.Veterinary Pharmacies |
| 10.3.3.Online Pharmacies |
| 11.Rest of LA Latin America Swine Vaccines Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Vaccine Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Inactivated Vaccines |
| 11.1.2.Recombinant vaccines |
| 11.1.3.Live attenuated vaccines |
| 11.1.4.DNA vaccines |
| 11.1.5.Subunit vaccines |
| 11.1.6.Others |
| 11.2. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Viral Infections |
| 11.2.2.Bacterial Infections |
| 11.2.3.Parasitic Infection |
| 11.2.4.Fungal Infections |
| 11.2.5.Others |
| 11.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Veterinary Hospitals |
| 11.3.2.Veterinary Pharmacies |
| 11.3.3.Online Pharmacies |
| 12.2. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Viral Infections |
| 12.2.2.Bacterial Infections |
| 12.2.3.Parasitic Infection |
| 12.2.4.Fungal Infections |
| 12.2.5.Others |
| 12.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Veterinary Hospitals |
| 12.3.2.Veterinary Pharmacies |
| 12.3.3.Online Pharmacies |
| 13.2. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Viral Infections |
| 13.2.2.Bacterial Infections |
| 13.2.3.Parasitic Infection |
| 13.2.4.Fungal Infections |
| 13.2.5.Others |
| 13.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Veterinary Hospitals |
| 13.3.2.Veterinary Pharmacies |
| 13.3.3.Online Pharmacies |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Zoetis |
| 14.2.2.Merck & Co. Inc. |
| 14.2.3.Virbac S.A |
| 14.2.4.Boehringer Ingelheim Vetmedica |
| 14.2.5.Elanco |
| 14.2.6.Bayer Animal Health |
| 14.2.7.Ceva Sante Animale |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.